Article
Development and Initial Validation of the Quality of life Evaluation in <i>NF2</i> -related Schwannomatosis Trials (QUEST) Assessment
2026-06-18
Abstract excerpt
Individuals with NF2 -related schwannomatosis ( NF2 -SWN) experience a complex constellation of physical, emotional, and social symptoms that substantially impact quality of life (QoL). Although disease-specific patient-reported outcome measures are increasingly important for evaluating treatment benefit in clinical trials, existing NF2 -SWN QoL measures have limitations in content coverage and sensitivity to c...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 58d75c0e-6087-537a-a963-567be6a9be07
- DOI
- 10.64898/2026.06.09.26355287
